Form D · Biotechnology
IMAGING3 INC
Burbank, CA · CIK 0001205181
Offering snapshot reported Jul 15, 2016 · SEC filing
- Reported sold
- $42K Offering amount: $500K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Jul 5, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2016 | Initial | $42,000 | No comparison | 7 | SEC filing |
| Jan 13, 2015 | Initial | $53,000 | No comparison | 6 | SEC filing |
| Dec 1, 2014 | Initial | $17,500 | No comparison | 2 | SEC filing |
| Oct 17, 2014 | Initial | $430,750 | No comparison | 44 | SEC filing |
| Apr 15, 2014 | Initial | $200,697 | No comparison | 10 | SEC filing |
| Sep 20, 2012 | Initial | $274,450 | No comparison | 27 | SEC filing |
| May 17, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 29, 2011 | Initial | $95,500 | No comparison | 5 | SEC filing |
| Oct 11, 2011 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
| Jun 14, 2011 | Initial | $355,771 | No comparison | 18 | SEC filing |
| Oct 26, 2010 | Initial | $1,000,000 | No comparison | 2 | SEC filing |
| Oct 8, 2009 | Initial | $1,098,500 | No comparison | 67 | SEC filing |
| Sep 14, 2009 | Initial | $106,379 | No comparison | 12 | SEC filing |
| Sep 14, 2009 | Initial | $492,000 | No comparison | 36 | SEC filing |
| Sep 10, 2009 | Initial | $536,596 | No comparison | 48 | SEC filing |
| Mar 5, 2009 | Initial | $308,000 | No comparison | Not reported | SEC filing |
| Jul 31, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 31, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 31, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 17, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 17, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $50K (estimated)
- Form D file number
- 021-267153
Source: Form D, filed Jul 15, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Xavier Aguilera | Director, Executive |
| Haykaz Balian | Director |
| Raul Carrega | Director |
| Dean Janes | Director, Executive |
| Richard Klug | Director |
| William Lu | Director |
| Art Lu | Director |
| Dane Medley | Director, Executive |
| Christopher Sohn | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3022 North Hollywood Way
Burbank, CA, 91505
Burbank, CA, 91505